Pancreatic Cancer News
Fiyinfolu Balogun, MD, PhD, Assistant Professor, Memorial Sloan Kettering Cancer Center, Awarded 2024 LEAD Project Grant WOODBURY, N.Y., May 30, 2024 — The Lustgarten Foundation has announced that the 2024 […]
Linda Resar, MD, Professor of Medicine, Oncology, and Pathology, Johns Hopkins University, Awarded 2024 Innovation and Collaboration Program Grant WOODBURY, N.Y., May 27, 2024 — The Lustgarten Foundation announced today […]
WOODBURY, NY, April 11, 2024 – The Lustgarten Foundation, in collaboration with the American Association for Cancer Research (AACR), has announced the 2024 recipients of the Lustgarten-AACR Career Development Awards […]
On Tuesday, March 12, 2024, we celebrated International Women’s Day at the prestigious Salk Institute for Biological Studies for “The Power of Persistence: Women Transforming Cancer Research & Care.” This […]
With thanks and appreciation to our contributing partner, Let’s Win Pancreatic Cancer. The U.S. Food and Drug Administration has approved irinotecan liposome (ONIVYDE) in combination with oxaliplatin, fluorouracil, and leucovorin, […]
From Lets Win Pancreatic Cancer – The 2025 ASCO Gastrointestinal Cancers Symposium, held from January 18 to 20 in San Francisco, California, once again highlighted the remarkable progress being made […]
Salk Institute researchers discovered that an anti-cancer therapy can prevent the activation of fibroblasts, cells that typically form protective barriers around pancreatic tumors. Read more about this Lustgarten-funded study.
Applications for the LEAD Project are due soon! Read more here.